John George Petrovich
Président chez Medallion Therapeutics, Inc.
Postes actifs de John George Petrovich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Medallion Therapeutics, Inc. | Président | 01/07/2017 | - |
Historique de carrière de John George Petrovich
Anciens postes connus de John George Petrovich
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AXONICS, INC. | Directeur/Membre du Conseil | 01/08/2013 | 04/03/2019 |
| Independent Dir/Board Member | 01/08/2013 | 04/03/2019 | |
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2000 | 31/10/2007 |
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | President | - | 16/09/2006 |
| The Alfred E. Mann Foundation For Scientific Research | Directeur Général | - | - |
| President | - | - |
Formation de John George Petrovich
| University of Southern California | Undergraduate Degree |
| University of California, Los Angeles | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| President | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| AXONICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Commercial Services |
| The Alfred E. Mann Foundation For Scientific Research | Miscellaneous |
| Medallion Therapeutics, Inc. |
- Bourse
- Insiders
- John George Petrovich
- Expérience
